ENDLOS-TURBO PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 09:34:44 2024-06-17 EDT | ||
| 4.26 EUR | +5.19% |
|
| Current month | -13.65% | ||
| 1 month | -10.79% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-17 | 4.26 | +5.19% |
| 24-06-14 | 4.05 | +4.38% |
| 24-06-13 | 3.88 | -8.92% |
| 24-06-12 | 4.26 | -5.33% |
| 24-06-11 | 4.5 | -1.32% |
Delayed Quote Deutsche Boerse AG
Last update June 17, 2024 at 09:34 am
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ2AM2 |
| ISIN | DE000DJ2AM28 |
| Date issued | 2023-09-08 |
| Strike | 272.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.614 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8 € |
|---|---|
| Lowest since issue | 0.51 € |
| Spread | 0.06 € |
| Spread % | 1.45% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
231.7
USD
Average target price
284.6
USD
Spread / Average Target
+22.85%
- Stock Market
- Certificates
- Certificat
